Inflam-D Tablet 400 mg is a nonsteroidal anti-inflammatory drug (NSAID) and is the active enantiomer of ibuprofen. It is used to relieve pain, reduce inflammation, and lower fever.
Inflam-D Tablet 400 mg is commonly used for:
| Brand Name | Inflam-D |
|---|---|
| Type | Tablet |
| Weight | 400 mg |
| Generic | Dexibuprofen |
| Manufacturer | Sanofi Bangladesh Ltd. |
| Available in | English বাংলা |
Inflam-D Tablet 400 mg works by inhibiting the activity of cyclooxygenase (COX) enzymes, particularly COX-2, which are involved in the synthesis of prostaglandins. Prostaglandins are compounds that mediate inflammation, pain, and fever. By reducing prostaglandin production, dexibuprofen alleviates these symptoms.
Inflam-D Tablet 400 mg typically begins to work within 30 to 60 minutes after oral administration. Peak effects are usually observed within 1 to 2 hours. The duration of effect can last for 4 to 6 hours.
Inflam-D Tablet 400 mg is well absorbed from the gastrointestinal tract. It reaches peak plasma concentrations approximately 1 to 2 hours after oral administration.
Inflam-D Tablet 400 mg is primarily metabolized in the liver. Its metabolites are then excreted mainly through the kidneys, with a small amount eliminated via the bile.
Typical dosages for dexibuprofen are:
Inflam-D Tablet 400 mg is administered orally, typically in the form of tablets or capsules. It should be taken with food or milk to minimize gastrointestinal irritation.
Common side effects include:
In case of overdose, symptoms may include severe nausea, vomiting, abdominal pain, dizziness, and tinnitus. Treatment generally involves supportive care, including monitoring and maintaining adequate hydration. Activated charcoal may be used if overdose is recent.
Precautions include:
Inflam-D Tablet 400 mg may interact with:
Inflam-D Tablet 400 mg should be used with caution in patients with:
Drug interactions include:
Taking dexibuprofen with food can help reduce gastrointestinal irritation. There are no significant food interactions reported.
Inflam-D Tablet 400 mg is generally not recommended during pregnancy, particularly in the third trimester, due to potential risks to the fetus, such as cardiovascular effects and premature closure of the ductus arteriosus. Consult a healthcare provider for appropriate alternatives if needed during pregnancy.
Inflam-D Tablet 400 mg is excreted in breast milk in small amounts. It is generally considered safe for use during lactation, but it's advisable to use the lowest effective dose and consult a healthcare provider.
Acute overdose can result in symptoms such as severe gastrointestinal distress, renal failure, and central nervous system effects like drowsiness or confusion. Management includes supportive care, maintaining hydration, and monitoring vital signs. Activated charcoal may be used if the overdose is recent.
Inflam-D Tablet 400 mg is contraindicated in:
Follow the dosage instructions provided by your healthcare provider or as specified on the medication label. It is important to use dexibuprofen at the lowest effective dose for the shortest duration necessary to manage symptoms. Consult a healthcare provider if you have any concerns or experience adverse effects.
Store dexibuprofen at room temperature, away from moisture and direct sunlight. Keep the medication out of reach of children and follow any additional storage instructions provided on the packaging.
The volume of distribution for dexibuprofen is approximately 0.1 to 0.2 L/kg, indicating that it is distributed throughout body tissues, including the central nervous system.
The half-life of dexibuprofen is approximately 2 to 4 hours, which may vary depending on individual factors such as age, liver function, and dose.
Inflam-D Tablet 400 mg is primarily cleared through the kidneys. The clearance rate can vary based on renal function and dosage, with adjustments necessary in patients with impaired renal function.
See in details version Inflam-D Tablet 400 mg also Inflam-D Tablet 400 mg in bangla